SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9324343
Source:
http://linkedlifedata.com/resource/pubmed/id/9324343
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006826
,
umls-concept:C0183683
,
umls-concept:C0344211
,
umls-concept:C0927232
,
umls-concept:C1171411
,
umls-concept:C1317973
,
umls-concept:C1328050
,
umls-concept:C1518999
,
umls-concept:C1521721
,
umls-concept:C1521725
,
umls-concept:C1705294
pubmed:issue
6
pubmed:dateCreated
1997-10-15
pubmed:abstractText
The outlook for many brain tumors remains poor. Increased dose intensity has been correlated with response rate and survival in many solid tumors.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P01CA59348
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7506654
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0098-1532
pubmed:author
pubmed-author:CaldemeyerKK
,
pubmed-author:HannaMM
,
pubmed-author:HeifetzS ASA
,
pubmed-author:JakackiR IRI
,
pubmed-author:JamisonCC
,
pubmed-author:SenderLL
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
553-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9324343-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:9324343-Brain Neoplasms
,
pubmed-meshheading:9324343-Child
,
pubmed-meshheading:9324343-Child, Preschool
,
pubmed-meshheading:9324343-Combined Modality Therapy
,
pubmed-meshheading:9324343-Drug Administration Schedule
,
pubmed-meshheading:9324343-Etoposide
,
pubmed-meshheading:9324343-Feasibility Studies
,
pubmed-meshheading:9324343-Female
,
pubmed-meshheading:9324343-Granulocyte Colony-Stimulating Factor
,
pubmed-meshheading:9324343-Hematopoietic Stem Cell Transplantation
,
pubmed-meshheading:9324343-Humans
,
pubmed-meshheading:9324343-Male
,
pubmed-meshheading:9324343-Neoplasm Recurrence, Local
,
pubmed-meshheading:9324343-Survival Analysis
,
pubmed-meshheading:9324343-Treatment Failure
pubmed:year
1997
pubmed:articleTitle
Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.
pubmed:affiliation
Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202-5225, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Controlled Clinical Trial